BDSX

BIODESIX INC

• Benzinga·20h ago

  Biodesix Announces That The American College Of Chest Physicians Has Published A New Framework For Clinical Practice, "Building A Lung Nodule Program: From Detection To Diagnosis."

• Benzinga·1d ago

  Biodesix Adds AI-Powered Imaging Test To Expand Lung Cancer Risk Screening

• Dow Jones·10/13 16:08

  Biodesix Is Maintained at Buy by TD Cowen

• Benzinga·10/13 15:58

  TD Cowen Maintains Buy on Biodesix, Raises Price Target to $40

• TipRanks·10/13 12:35

  Biodesix price target raised to $40 from $30 at TD Cowen

• Benzinga·10/13 10:26

  Biodesix Announces Multiple Presentations At CHEST 2026 Highlighting How Nodify Lung Testing Is Being Incorporated Into Real-World Lung Nodule Management

• NASDAQ·10/02 14:00

  Biodesix Consensus Price Target Raised by 12.20% to $37.54

• Dow Jones·09/28 09:53

  Biodesix Is Maintained at Buy by HC Wainwright & Co.

• Dow Jones·09/28 09:53

  Biodesix Price Target Raised to $38.00/Share From $27.00 by HC Wainwright & Co.

• NASDAQ·09/27 12:23

  Biodesix Reveals Two Developing MRD Solution Collaborations With Bio-Rad And Thermo Fisher

• TipRanks·09/25 16:30

  Biodesix price target raised to $38 from $27 at H.C. Wainwright

• TipRanks·09/24 13:10

  Analysts Are Bullish on These Healthcare Stocks: QuidelOrtho (QDEL), Merck & Company (MRK)

• Benzinga·09/24 10:36

  Biodesix Announces Progress In Two Collaborative Programs For Tumor-informed And Tumor-naïve Molecular Residual Disease Solutions

• TipRanks·09/24 10:15

  Biodesix advances two programs for Molecular Residual Disease monitoring

• TipRanks·09/22 13:55

  Craig-Hallum sees potential for confusion after CMS fee schedule